A Contemporary Comparison of Laparoscopic versus Open Partial Nephrectomy for Renal Cell Carcinoma

Author:

Nicaise Edouard1,Feldman Adam S.1,Gusev Andrew1,Yu Alice2,Nimmagadda Naren3,Wszolek Matthew F.1,McGovern Francis1,Blute Michael L.1,Dahl Douglas M.1

Affiliation:

1. Massachusetts General Hospital

2. H. Lee Moffitt Cancer Center

3. Johns Hopkins University School of Medicine

Abstract

Abstract Purpose: To analyze surgical and oncologic outcomes of patients undergoing open partial nephrectomy (OPN) versus laparoscopic partial nephrectomy (LPN) for treatment of renal cell carcinoma (RCC). Methods: We retrospectively investigated our institutional RCC database for patients who underwent PN for RCC from 1997-2018. Decision for technique was at the discretion of the operating urologist, following practice patterns and training history. Outcomes analyzed included pre/peri/post-operative parameters, pathologic outcomes, and disease recurrence rates. Results: 1088 patients underwent PN from 1997-2018. After exclusionary criteria, 631 patients who underwent 647 unique PNs for a total of 162 OPN and 485 LPN remained. Baseline, pre-op, and pathologic characteristics were not different. Surgical time was lower in laparoscopic cases [185 vs 205 minutes] (p = 0.013). Margin involvement was not different; LPN had lower estimated blood loss (EBL) [150 vs 250 mL] (p < 0.001) and longer ischemia time [21 vs 19 min] (p = 0.005). LPN had shorter length of stay [2 vs 4 days] (p < 0.001), fewer overall complications (p < 0.001), and no difference in high-grade complications [2.89 vs 4.32%] (p = .379). Fewer LPN patients developed metastases [1.65 vs 4.94%] (p = 0.0499). Local recurrence rates were not different [1.24 vs 3.09%] (p = 0.193). Renal function was equivalent between cohorts post-operatively. Conclusion: Our results show that LPN has equivalent oncologic outcomes to OPN, with no difference in patient and tumor characteristics. LPN was associated with lower EBL, shorter length of stay, and lower overall complication risk. Renal function was equally maintained.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3